U.S. patent appeals panel delivers loss to Moderna in mRNA vaccine case

by
Contributor since / Followers

4 weeks ago

The Patent Trial and Appeals Board of the U.S. Patent and Trademark Office has thrown out portions of two patents held by Moderna (NASDAQ:MRNA) regarding mRNA encoding in vaccines.
Moderna, which makes an mRNA-based COVID-19 vaccine, has accused BioNTech (

Tags: PFE